Triazolyl phenyl benzenesulfonamides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481579
APP PUB NO 20120165303A1
SERIAL NO

13411171

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CHEMOCENTRYX, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Charvat, Trevor T San Jose, US 24 524
Hu, Cheng Menlo Park, US 68 411
Melikian, Anita San Francisco, US 18 276
Novack, Aaron San Jose, US 16 353
Pennell, Andrew M K San Francisco, US 37 521
Punna, Sreenivas Sunnyvalle, US 75 884
Sullivan, Edward J San Jose, US 18 207
Tan, Xuefei Union City, US 56 230
Thomas, William D San Jose, US 28 427
Ungashe, Solomon Fremont, US 45 823
Zeng, Yibin San Mateo, US 94 1037

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00